| 538 | 0 | 38 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 运用中药网络药理学方法结合分子对接技术,初步探究甘草泻心汤治疗化疗后恶心呕吐(chemotherapy-induced nausea and vomiting,CINV)的作用机制。方法 从中药系统药理学数据库和分析平台获取甘草泻心汤的活性化合物及其作用靶点;使用Perl软件通过UniProt数据库匹配靶点对应的标准基因符号;从GeneCards、OMIM、PharmGKB、Therapeutic Target Database和DrugBank 5个数据库中检索CINV相关疾病靶点基因;利用R软件筛选甘草泻心汤靶点与CINV靶点的交集基因;通过Cytoscape 3.10.3软件绘制“药物-成分-靶点-疾病”交互网络图;基于STRING平台构建蛋白质-蛋白质相互作用网络;对关键活性成分与核心靶点进行分子对接,验证其结合活性;采用R 4.2.2软件进行基因本体(gene ontology,GO)功能富集分析和京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)通路富集分析。结果 基于口服生物利用度(oral bioavailability,OB)和类药性(drug-likeness,DL)阈值筛选,获得甘草泻心汤118种去重活性成分,甘草泻心汤与CINV存在31个共同作用靶点。GO富集分析共获得1831条显著条目,包括生物过程1621条、细胞组分79条和分子功能131条;KEGG通路分析筛选出128条相关通路。甘草泻心汤的主要活性成分为槲皮素、β-谷甾醇、汉黄芩素、山柰酚、荷叶碱;核心靶点为蛋白激酶B、白细胞介素-1β、细胞间黏附分子-1、肿瘤蛋白p53、表皮生长因子受体、前列腺素内过氧化物合酶2、B细胞淋巴瘤-2、雌激素受体α、连环蛋白β1。分子对接表明,活性成分(如槲皮素)与核心靶点前列腺素内过氧化物合酶2结合稳定,作用机制涉及外源性刺激响应、胶质细胞增殖、细胞凋亡等生物过程,并通过调控磷脂酰肌醇3激酶-蛋白激酶B、缺氧诱导因子-1、Janus激酶-信号转导子和转录激活子等信号通路发挥抗CINV作用。结论 甘草泻心汤通过槲皮素、β-谷甾醇、汉黄芩素等活性成分,作用于蛋白激酶B、前列腺素内过氧化物合酶2等多靶点,调控炎症反应、细胞凋亡及相关信号通路,从而发挥治疗化疗后恶心呕吐的作用。
Abstract:Objective To explore the mechanism of Gancao Xiexin Tang in treating chemotherapy-induced nausea and vomiting(CINV) using traditional Chinese medicine network pharmacology methods combined with molecular docking technology. Methods The active compounds and their targets of Gancao Xiexin Tang were obtained from the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform TCMSP. Perl software was used to match the standard gene symbols corresponding to the targets in the UniProt database. CINV related disease target genes were retrieved from five databases: GeneCards, OMIM, PharmGKB, Therapeutic Target Database, and DrugBank. Using R software to screen the intersection genes between the targets of Gancao Xiexin Tang and CINV, a "drug ingredient target disease" interaction network diagram was drawn using Cytoscape 3.10.3 software. A protein-protein interaction network was constructed based on the STRING platform to perform molecular docking between key active ingredients and core targets to verify their binding activity. Gene ontology(GO) functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analysis were performed using R 4.2.2 software. Results Based on oral bioavailability(OB) and drug likeness(DL) threshold screening, 118 de duplicated active ingredients were obtained from Gancao Xiexin Tang. Gancao Xiexin Tang has 31 common targets with CINV. GO enrichment analysis showed a total of 1831 significant entries, including 1621 for biological processes, 79 for cellular components, and 131 for molecular functions; KEGG pathway analysis identified 128 relevant pathways. The main active ingredients of Gancao Xiexin Tang are quercetin, β-sitosterol, baicalein, kaempferol, and hesperetin; The core targets are AKT1, IL-1 β, ICAM1, TP53, EGFR, PTGS2, BCL2, ESR1, and CTNNB1. Molecular docking showed that the active ingredient(such as quercetin) binds stably to the core target PTGS2, and its mechanism of action involves biological processes such as exogenous stimulus response, glial cell proliferation, and apoptosis. It exerts anti CINV effects by regulating signaling pathways such as PI3K-Akt, HIF-1, JAK-STAT, etc. Conclusion Gancao Xiexin Tang acts on multiple targets such as Akt1 and PTGS2 through active ingredients such as quercetin, β-sitosterol, and baicalein, regulating inflammatory response, cell apoptosis, and related signaling pathways, thereby treating nausea and vomiting after chemotherapy.
[1]上海市抗癌协会癌症康复与姑息治疗专业委员会,上海市抗癌协会肿瘤药物临床研究专业委员会,中国老年保健协会肿瘤防治与临床研究管理专业委员会.抗肿瘤治疗所致恶心呕吐全程管理上海专家共识(2024年版)[J].中国癌症杂志,2024,34(1):104-134.
[2]GUPTA K,WALTON R,KATARIA S P. Chemotherapy-induced nausea and vomiting:pathogenesis,recommendations,and new trends[J]. Cancer Treat Res Commun,2021,26:100278.
[3]HE L J,WANG J Z,PU W G,et al. Prospective clinical evidence from over 1,000 pan-cancer patients:a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting[J]. BMC Cancer,2025,25(1):82.
[4]林家兴,李慧杰,李秀荣.基于“顾护脾胃”论治化疗相关性呕吐[J].中国中西医结合消化杂志,2022,30(10):739-742.
[5]王学语,何丹,孙金芳.中医药治疗肺癌化疗相关性恶心呕吐研究进展[J].光明中医,2022,37(8):1503-1506.
[6]中国抗癌协会癌症康复与姑息治疗专业委员会,中国抗癌协会肿瘤临床化疗专业委员会,中国抗癌协会肿瘤支持治疗专业委员会,等.中国抗肿瘤治疗相关恶心呕吐预防和治疗指南(2023版)[J].中华肿瘤杂志,2024,46(6):481-501.
[7]苏凯莹.甘草泻心汤联合西药防治乳腺癌延迟性CINV的临床研究[D].广州:广州中医药大学,2019.
[8]葛国艳.加减甘草泻心汤对肺癌中晚期患者化疗后胃肠道反应的临床观察[J].中医临床研究,2022,14(5):49-53.
[9]李翠艳,蒋丹苹,王丽萍.加减甘草泻心汤对肺癌中晚期患者化疗后胃肠道反应的临床观察[J].实用中医内科杂志,2023,37(7):115-117.
[10]彭巧林.加味甘草泻心汤联合西药防治化疗所致恶心呕吐的临床观察[D].成都:成都中医药大学,2022.
[11]朱俊霞,史佩玉,綦向军,等.基于网络药理学和分子对接的半夏泻心汤治疗慢性萎缩性胃炎作用机制探讨[J].药物评价研究,2021,44(1):98-110.
[12]李艳娇,李双阳,唐红梅,等.基于网络药理学和分子对接探讨大黄-三七配伍治疗脑出血机制及其实验验证[J].中西医结合心脑血管病杂志,2023,21(19):3478-3489.
[13]莫嘉浩,许洪彬,李菁,等.基于网络药理学的左金丸治疗肝癌机制探讨[J].中国中医药信息杂志,2021,28(2):19-27.
[14]张舟妙,江滔,李苗霞.中药防治化疗所致恶心呕吐的网络药理学研究[J].中国中医药现代远程教育,2024,22(15):91-94.
[15]PHAM T N H,NGUYEN T H,TAM N M,et al. Improving ligand-ranking of AutoDock Vina by changing the empirical parameters[J]. J Comput Chem,2022,43(3):160-169.
[16]奚爱妮,胡晶晶,单洪强,等.甘草泻心汤加减联合毫针治疗颜面部痤疮对皮损积分及免疫功能的影响[J].辽宁中医杂志,2024,51(7):165-168.
[17]ZHANG H,TIAN Y,XU C J,et al. Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer[J].Cell Death Discov,2025,11(1):78.
[18]王亚茹,袁满,张丽,等.槲皮素抗氧化作用及相关机制研究进展[J].营养学报,2022,44(2):204-208.
[19]余良昆,李勇,钟发明,等.皮素调控Nrf2/HO-1信号通路抗氧化应激的机制研究[J].江西中医药大学学报,2023,35(6):78-82,88.
[20]SUN W,CHEN Y X,WANG L,et al. Gram-scale preparation of quercetin supramolecular nanoribbons for intestinal inflammatory diseases by oral administration[J]. Biomaterials,2023,295:122039.
[21]张文文,向施,陈慧,等.β-谷甾醇对肿瘤的防治作用及其机制研究进展[J].医药导报,2024,43(5):757-761.
[22]田华,王小平,张峰利.黄芩素对慢性萎缩性胃炎大鼠胃粘膜保护作用的实验研究[J].中医药通报,2015,14(5):62-64.
[23]朱亚南,杨七妹,张硕,等.黄芩苷与黄芩素药理作用及机制研究进展[J].时珍国医国药,2020,31(4):921-925.
[24]杨钊,臧婷,马凯,等.基于PI3K/AKT信号通路研究山柰酚在食管鳞癌中的抗肿瘤作用[J].医学分子生物学杂志,2024,46(4):354-360.
[25]余秋香,李思雨,常安,等.消食颗粒化学成分鉴定及其治疗功能性消化不良的潜在作用机制研究[J].中国药房,2022,33(23):2874-2879.
[26]祝珊珊,谭博文,秦飞,等.槲皮素通过PTEN/PI3K/JNK信号通路减轻小鼠RAW264.7巨噬细胞炎症[J].中国病理生理杂志,2023,39(3):510-519.
[27]王峥业,魏玉梅,陈大贵.山柰酚通过激活PI3K/AKT/mTOR信号通路改善视网膜氧化应激损伤[J].徐州医科大学学报,2024,44(4):243-249.
[28]NING X Y,LUO D P,CHEN Y,et al. Baicalin reduces renal inflammation in mesangial proliferative glomerulonephritis through activation of Nrf2/ARE and PI3K/AKT pathways[J].Discov Med,2023,35(176):372-382.
[29]NAVARI R M. Treatment of breakthrough and refractory chemotherapy-induced nausea and vomiting[J]. Biomed Res Int,2015,2015:595894.
[30]徐雪梅,徐森,周国坤,等.恶心呕吐的分子机制及神经回路研究进展[J].中国疼痛医学杂志,2024,30(11):804-814.
基本信息:
DOI:10.26950/j.issn.2097-5031.2026.01.003
中图分类号:R285
引用信息:
[1]宋浩,黄小辉,吴沅学,等.基于网络药理学和分子对接的甘草泻心汤治疗化疗后恶心呕吐作用机制探讨[J].中西医结合慢性病杂志,2026,3(01):15-22.DOI:10.26950/j.issn.2097-5031.2026.01.003.
基金信息:
重庆市铜梁区中医院科研中医临床专项(22)
2025-03-12
2025
2026-01-23
2026
2
2025-09-12
2025-09-12
2025-09-12